Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bixiang Zhang

Showing results (191-200 of 226) with videos related to

Pageof 23
Sort By:
Medcomm|July 2, 2024
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38Yi He, Shenqi Han, Han Li, et al.
Oncogene|February 10, 2022
DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6Xiaochao Zhang, Yabing Hu, Yonglong Pan, et al.
Hepatology (Baltimore, Md.)|July 22, 2025
NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinomaQibo Huang, Weijian Wang, Qianyun Ge, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2023
Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5pShenqi Han, Lin Xue, Yi Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2024
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA AxisJingyuan Wen, Lin Xue, Yi Wei, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 28, 2022
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathwayYonglong Pan, Mengzhen Han, Xiaochao Zhang, et al.
Plos One|August 11, 2015
An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicumXin Long, Qian Chen, Jianping Zhao, et al.
Hepatology (Baltimore, Md.)|January 7, 2020
PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-β Receptor 1Zhibin Liao, Lin Chen, Xuewu Zhang, et al.
Hepatobiliary Surgery and Nutrition|December 1, 2018
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensusTianfu Wen, Chen Jin, Antonio Facciorusso, et al.
Pageof 23

Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
Medcomm|July 2, 2024
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38Yi He, Shenqi Han, Han Li, et al.
Oncogene|February 10, 2022
DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6Xiaochao Zhang, Yabing Hu, Yonglong Pan, et al.
Hepatology (Baltimore, Md.)|July 22, 2025
NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinomaQibo Huang, Weijian Wang, Qianyun Ge, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2023
Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5pShenqi Han, Lin Xue, Yi Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2024
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA AxisJingyuan Wen, Lin Xue, Yi Wei, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 28, 2022
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathwayYonglong Pan, Mengzhen Han, Xiaochao Zhang, et al.
Plos One|August 11, 2015
An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicumXin Long, Qian Chen, Jianping Zhao, et al.
Hepatology (Baltimore, Md.)|January 7, 2020
PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-β Receptor 1Zhibin Liao, Lin Chen, Xuewu Zhang, et al.
Hepatobiliary Surgery and Nutrition|December 1, 2018
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensusTianfu Wen, Chen Jin, Antonio Facciorusso, et al.
Pageof 23